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Tight glucose regulation is beneﬁ   cial in subgroups of 
inten  sive care unit (ICU) patients, but may harm other 
sub groups.  Th  is harm may be due to hypoglycemic 
events. In avoiding hypoglycemia, an accurate bedside 
glucometry method is essential [1].
Bridges and colleagues therefore evaluated the accuracy 
of a continuous subcutaneous glucose monitoring system 
(CGMS) in critically ill children, and concluded that the 
system proves highly accurate [2]. We have a problem 
with this resolute conclusion. Th  ey report a Pearson’s 
correlation coeﬃ   cient of 0.68, which is quite low. Vlkova 
and colleagues even conclude that, based on a correlation 
coeﬃ     cient of 0.69 comparing subcutaneous glucose 
values and laboratory blood glucose values in 15 patients, 
subcutaneous devices should not be used in critically ill 
patients [3]. We found a correlation coeﬃ   cient of 0.87 in 
evaluating the same CGMS in 60 critically ill patients, 
but were concerned with the inaccuracy in the low 
glucose zone: we found a diﬀ  erence of nearly 4 mmol/l 
(reference blood glucose 2.8 mmol/l versus subcutaneous 
sensor 6.5 mmol/l) in one patient [4]. Bridges and 
colleagues report 142 subcutaneous glucose readings 
<2.2 mmol/l that were falsely low, checked against blood 
glucose values.
Th  e Clarke error grid is a better way to evaluate the 
accuracy of a CGMS than Pearson’s correlation coeﬃ   -
cient. In most published studies, the deviation of subcu-
ta  neous measurements stays in the (wide) clinically 
accep  table zones of the Clarke error grid. Th  ese 
deviations of the CGMS system, however, when used in a 
tight glucose regulation protocol – and adjusting the 
insulin dose based on the subcutaneous readings – could 
have severe consequences in the individual patient, if the 
deviations result in an unjust rise in insulin dose. Since 
computerized protocols based on arterial blood samples 
give excellent glucose regulation with a negligible chance 
of hypoglycemic events [5], we decided to continue using 
this computerized protocol to avoid treatment-related 
morbidity. Subcutaneous CGMS seems not good enough 
in aiming for tight glucose regulation in the ICU. 
Intravascular CGMS, used in a closed feedback loop with 
insulin infusion, is promising, but has not yet been 
evaluated in clinical studies in critically ill patients.
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We appreciate the points raised by Dr Ligtenberg and 
colleagues. Th   ey suggest that because continuous glucose 
monitor (CGM) evaluations have not exceeded a speciﬁ  c 
Pearson’s coeﬃ     cient, intro  ducing their use in ICUs is 
imprudent [2-4]. We believe the Pearson coeﬃ   cient for 
our data is strong (that is, >0.6) and our Clarke error grid 
analysis (that is, Zone A + B >95%) and mean absolute 
relative diﬀ   erence (15.3%) are in line with regulatory 
agency approval of such devices, albeit for outpatient use 
[2].
Unfortunately this group does not recommend an 
acceptable Pearson’s coeﬃ   cient, how a Pearson’s coeﬃ     -
cient should be integrated with other objective assess-
ments, or how these criteria should be modiﬁ  ed depend-
ing on the proposed role of CGMs in ICU care. Agreed, it 
would be premature to use data solely from CGMs to 
direct insulin titrations in ICUs. As one hour or more 
may pass between glucose checks in many ICU glycemic 
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© 2011 BioMed Central Ltdcontrol protocols, there may be important beneﬁ  ts of a 
technology with minute-to-minute readings that closely 
correlates with blood glucose levels. Adjunctive devices 
that continuously display surrogate, but closely corre-
lated, patient data are not uncommon in ICUs, for 
example end-tidal carbon dioxide readings are often used 
as a proxy for arterial carbon dioxide levels and can be a 
vital asset in the management of mechanical ventilation. 
CGMs that display up-to-the minute glucose trends with 
alarms set at critical thresholds (incorporating leeway for 
inaccu  racy) could be used to trigger routine blood 
glucose measures to guide clinical management [2].
True, we had few (0.2% of >64,000) CGM readings and 
no blood glucose readings of <40 mg/dl (2.2 mmol), and 
thus cannot remark on the accuracy of CGMs in the 
severe hypoglycemic range. Yet we contend that if CGM 
devices can help maintain blood glucose levels in normo-
glycemic ranges they may provide critical assistance in 
avoiding hypoglycemia and thus their precision in low 
blood glucose ranges may be of less importance.
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